Abstract:The accuracy in Anti-tuberculous drug assaying was supported by computational modeling using a 2 and 3-dimensional thermodynamic binding affinity prediction of each drug during multiple drug co-administration regimens. The United States Food and Drug Administration has highlighted the need for extensive research to improve the recovery during analytical drug method development, where the recovery affects the slope of the calibration curve. Here we focused on the drug-protein binding variation that affects the extrapolation of the patient sample drug concentration from the slope of the calibration curve. The binding constants calculated at a physiological temperature from the fluorescence spectroscopy data were as follows: Rifampicin 5.379 X 102 M-1 (moderate affinity), Isoniazid 9.285 M-1 (low affinity), 25-Desacetyl Rifampicin 3.156 M-1 (low affinity), Ethambutol 3.443 M-1 (low affinity) and Pyrazinamide 3.076 X 102 M-1 (moderate affinity). These drugs Gibbs free energy were below zero, indicating spontaneous binding reactions. Rifampicin a non-polar weak acid with a higher affinity indicating the most stable complex formation with albumin as opposed to soluble Isoniazid due to it being polar and an ionized form to be easily excreted in the urine resulting in low levels of detection. This will affect the bioavailability and accuracy of the assay levels for patients experiencing hyper and hypoalbuminemia with related competition and induction processes of the enzymes. These complications are apparent where larger numbers of patients are involved in clinical trials, bioequivalence and bioavailability studies with varying protein levels that may be more crucial for drugs with a narrow therapeutic index.

Probing amikacin interaction with albumin: A combined multispectral and molecular docking investigation

Study on interaction between ampicillin antibody and detection interfering proteins by computer aided protein-protein docking for biosensor interesting

Biophysical and molecular docking approaches for the investigation of biomolecular interactions between amphotericin B and bovine serum albumin

Identification of the Binding Interaction of Anti-tuberculous Drugs with Human Serum Albumin: A Computational Molecular Docking, Fluorescence and Absorption Spectroscopy Study

Binding of Teicoplanin and Vancomycin to Bovine Serum Albumin in Vitro: a Multispectroscopic Approach and Molecular Modeling

Probing into the binding interaction between medroxyprogesterone acetate and bovine serum albumin (BSA): spectroscopic and molecular docking methods.

Probing the intermolecular interactions into serum albumin and anthraquinone systems: a spectroscopic and docking approach

Characterizing the Binding Interaction Between Antimalarial Artemether (amt) and Bovine Serum Albumin (bsa): Spectroscopic and Molecular Docking Methods

Evaluating the Effect of Aminoglycosides on the Interaction Between Bovine Serum Albumins by Atomic Force Microscopy

Recognition and Binding of Β-Lactam Antibiotics to Bovine Serum Albumin by Frontal Affinity Chromatography in Combination with Spectroscopy and Molecular Docking.

In vitro study on binding interaction of quinapril with bovine serum albumin (BSA) using multi-spectroscopic and molecular docking methods.

Multifaceted analysis of bempedoic acid binding to subdomain IIA of human serum albumin

Structural and ligand-binding properties of serum albumin species interacting with a biomembrane interface

Combined Spectroscopies and Molecular Docking Approach to Characterizing the Binding Interaction of Enalapril with Bovine Serum Albumin.

Binding Interaction of Atorvastatin with Bovine Serum Albumin: Spectroscopic Methods and Molecular Docking.

The Interaction Between 4-Aminoantipyrine and Bovine Serum Albumin: Multiple Spectroscopic and Molecular Docking Investigations

Studies on Interactions of Antibiotics with Serum Albumin by Surface Plasmon Resonance Biosensor

A Comprehensive Multispectroscopic and Computational Analysis of the Interaction between Plant-Based Antiplasmodial Compounds and Bovine Serum Albumin

Probing the Interaction of Cefodizime with Human Serum Albumin Using Multi-Spectroscopic and Molecular Docking Techniques.

Spectroscopic Studies on the Interaction Between an Anticancer Drug Ampelopsin and Bovine Serum Albumin

Understanding the mode of binding mechanism of doripenem to human serum albumin: Spectroscopic and molecular docking approaches